1. Home
  2. Search Clinical Trials
Search
Filters
Clear All
  • 49
  • 59
  • 6
  • 3
  • 497

Phase

  • 18
  • 14
  • 3
  • 14
  • 6
  • 15
  • 2
  • 439
  • 580
  • 230
  • 603
  • 11
  • 53
  • 26
  • 6
  • 608

Found 614 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:

A Phase 1 First-in-Human Open-label Study Evaluating the Safety Tolerability Pharmacokinetics and Efficacy of AMG 510 in Subjects With Advanced Solid Tumors With a Specific KRAS Mutation.

18 years - 100 years
All genders
This research study is being done to test the effects of a new investigational drug therapy called AMG 510 which is being investigated for the treatment of advanced solid tumors with a specific KRAS mutation.
Learn More

Family Processes in Developmental Outcomes of Pediatric Hearing Loss

3 years - 8 years
All genders
The purpose of this study is to understand the contribution of family environment to the developmental outcomes of children with hearing loss.
Learn More

Intervention to Change Attributions that are Negative (ICAN): a New Approach to Reducing Anger and Aggression after Brain Injury"

18 years - 65 years
All genders
Anger is common after TBI. Past studies show that anger can sometimes be the result of the way a person thinks about other peoples behaviors. We developed a group therapy program, ICAN, in order to help you think differently about other peoples behaviors.
Learn More

A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) with Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed and Refractory Hematologic Malignancies

18 years - 65 years
All genders
The purposes of this study are to: (1) find the most effective dose of a new type of radiation therapy called total marrow irradiation (TMI) that will be given with the conditioning chemotherapy, fludarabine, to prepare patients for allogeneic hematopoietic stem cell transplantation (Allo-HSCT); and (2) see if utilization of …
Learn More

A Randomized Phase II Study of Anti-PD1 Antibody [MK-3475 (Pembrolizumab)] Alone Versus Anti-PD1 Antibody Plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell Carcinoma

18 years - 100 years
All genders
This randomized phase II trial studies how well pembrolizumab with or without stereotactic body radiation therapy works in treating patients with merkel cell cancer that has spread to other places in the body.
Learn More

Prosodic Position in Cross Language Perception and Production

18 years - 100 years
All genders
The purpose of this study is to determine how it is that people with different language experiences perceive speech sounds spoken by different people in different contexts. It also seeks to determine how people's language experience affects how they produce these sounds as well.
Learn More

Early Development of Action Understanding

1 years - 1 years
All genders
The goal of this study is to learn more about how infants perceive and represent observed actions.
Learn More

Cabazitaxel with Abiraterone versus Abiraterone alone Randomized Trial for Extensive Disease following Docetaxel: the CHAARTED2 Trial

18 years - 100 years
Male
This randomized phase II trial studies how well abiraterone acetate and antiandrogen therapy, with or without cabazitaxel and prednisone, work in treating patients with hormone-sensitive prostate cancer previously treated with docetaxel that has spread to other parts of the body.
Learn More

Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening: Reducing the Risk of Drug-Induced QT Interval Lengthening in Women

21 years - 100 years
Female
The purpose of this study is to determine the effectiveness of progesterone given by mouth for minimizing drug EKG response to a drug.
Learn More

VISION: An International Prospective Open Label Multicenter Randomized Phase 3 Study of 177Lu-PSMA-617 in the Treatment of Patients With Progressive PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)

18 years - 100 years
Male
The purpose this study is to compare overall survival (OS) in patients with progressive PSMA-positive mCRPC who receive 177Lu-PSMA-617 in addition to best supportive/best standard of care versus patients treated with best supportive/best standard of care alone.
Learn More
291 - 300 of 614